These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 16484873)

  • 21. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.
    Kozora E; Arciniegas DB; Filley CM; West SG; Brown M; Miller D; Grimm A; Devore MD; Wingrove C; Zhang L
    Arthritis Rheum; 2008 Nov; 59(11):1639-46. PubMed ID: 18975359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association of antiphospholipid antibodies with valvular heart disease in patients with systemic lupus erythematosus].
    Hosaka K; Okada J; Ogiwara A; Kobayashi A; Kondo H
    Ryumachi; 1994 Feb; 34(1):22-9. PubMed ID: 8146724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral and corpus callosum atrophy in systemic lupus erythematosus.
    Appenzeller S; Rondina JM; Li LM; Costallat LT; Cendes F
    Arthritis Rheum; 2005 Sep; 52(9):2783-9. PubMed ID: 16142703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristic manifestations of neuropsychiatric systemic lupus erythematosus].
    Liu Z; Chen L; Cui LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):509-12. PubMed ID: 16178450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis.
    Watad A; Tiosano S; Grysman N; Comaneshter D; Cohen AD; Shoenfeld Y; Amital H
    Eur J Clin Invest; 2017 May; 47(5):366-371. PubMed ID: 28295225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical analysis of cerebrospinal fluid interleukin-6 in neuropsychiatric systemic lupus erythematosus.
    Horai Y; Watanabe H; Miyamura T; Takahama S; Hirata A; Nakamura M; Ando H; Minami R; Yamamoto M; Suematsu E
    Fukuoka Igaku Zasshi; 2010 Feb; 101(2):34-40. PubMed ID: 20560477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE).
    Hermosillo-Romo D; Brey RL
    Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):229-44. PubMed ID: 12041951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging.
    Luyendijk J; Steens SC; Ouwendijk WJ; Steup-Beekman GM; Bollen EL; van der Grond J; Huizinga TW; Emmer BJ; van Buchem MA
    Arthritis Rheum; 2011 Mar; 63(3):722-32. PubMed ID: 21360502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
    Farzaneh-Far A; Roman MJ; Lockshin MD; Devereux RB; Paget SA; Crow MK; Davis A; Sammaritano L; Levine DM; Salmon JE
    Arthritis Rheum; 2006 Dec; 54(12):3918-25. PubMed ID: 17133599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antineuronal antibodies and electroneurophysiological studies in pediatric patients with neuropsychiatric systemic lupus erythematosus.
    Mostafa GA; Nazif HK; El-Shahawi HH; Abd El-Aziz MM; Hassan MA
    Pediatr Allergy Immunol; 2009 Mar; 20(2):192-9. PubMed ID: 18422890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Hanly JG; Fisk JD; McCurdy G; Fougere L; Douglas JA
    J Rheumatol; 2005 Aug; 32(8):1459-6. PubMed ID: 16078320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral changes in SLE with or without antiphospholipid syndrome. a case-control MRI study.
    Valdés-Ferrer SI; Vega F; Cantú-Brito C; Ceballos-Ceballos J; Estañol B; García-Ramos G; Cabral AR
    J Neuroimaging; 2008 Jan; 18(1):62-5. PubMed ID: 18190498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension.
    Csépány T; Bereczki D; Kollár J; Sikula J; Kiss E; Csiba L
    J Neurol; 2003 Nov; 250(11):1348-54. PubMed ID: 14648152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus.
    Steens SC; Bosma GP; Steup-Beekman GM; le Cessie S; Huizinga TW; van Buchem MA
    Arthritis Res Ther; 2006; 8(2):R38. PubMed ID: 16469116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multisequence magnetic resonance imaging study of neuropsychiatric systemic lupus erythematosus.
    Bosma GP; Steens SC; Petropoulos H; Admiraal-Behloul F; van den Haak A; Doornbos J; Huizinga TW; Brooks WM; Harville A; Sibbitt WL; van Buchem MA
    Arthritis Rheum; 2004 Oct; 50(10):3195-202. PubMed ID: 15476212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus.
    Hopia L; Thangarajh M; Khademi M; Laveskog A; Wallström E; Svenungsson E; Andersson M
    Scand J Rheumatol; 2011; 40(5):363-72. PubMed ID: 21585290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Núñez-Alvarez CA; Llorente L; Sánchez-Guerrero J
    J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship Between Clinical and Immunological Features with Magnetic Resonance Imaging Abnormalities in Female Patients with Neuropsychiatric Systemic Lupus Erythematosus.
    Wang HP; Wang CY; Pan ZL; Zhao JY; Zhao B
    Chin Med J (Engl); 2016 Mar; 129(5):542-8. PubMed ID: 26904988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach.
    Lefranc D; Launay D; Dubucquoi S; de Seze J; Dussart P; Vermersch M; Hachulla E; Hatron PY; Vermersch P; Mouthon L; Prin L
    Arthritis Rheum; 2007 Oct; 56(10):3420-32. PubMed ID: 17907141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased lymphocyte death by neglect-apoptosis is associated with lymphopenia and autoantibodies in lupus patients presenting with neuropsychiatric manifestations.
    Silva LM; Garcia AB; Donadi EA
    J Neurol; 2002 Aug; 249(8):1048-54. PubMed ID: 12195452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.